Danaher (NYSE:DHR) shares rose more than 2% intra-day today after it received an upgrade from Hold to Buy from Stifel ...

Fintel reports that on March 14, 2025, Stifel upgraded their outlook for Danaher (NYSE:DHR) from Hold to Buy. Analyst Price ...

Following the rerating, Danaher shares seem to have found their footing, with downward [earnings] estimate revisions ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

Banco Santander increased its stake in Danaher by 56.2%, now holding 8,757 shares worth $2.01 million. Several other ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added ...

Welch & Forbes LLC increased its stake in Danaher by 1.3% in Q4, now holding 684,853 shares worth $157.2 million.

Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

Staff at Danaher Animal Home have welcomed a litter of 10 puppies, after the rescue's 'heavily pregnant stray' Saskia gave birth onsite.